Oxoplatin-Based Pt(IV) Lipoate Complexes and Their Biological Activity

Xiao Liu, Marie Christin Barth, Klaudia Cseh, Christian R. Kowol, Michael A. Jakupec, Bernhard K. Keppler*, Dan Gibson*, Wolfgang Weigand*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

11 Scopus citations

Abstract

α-Lipoic acid, known for its anti-inflammatory and antioxidant activity, represents a promising ligand for Pt(IV) prodrugs. Three new Pt(IV) lipoate complexes were synthesized and characterized by NMR spectroscopy (1H, 13C, 195Pt), mass spectrometry and elemental analysis. Due to the low solubility of the complex containing two axial lipoate ligands, further experiments to examine the biological activity were performed with two Pt(IV) complexes containing just one axial lipoate ligand. Both complexes exhibit anticancer activity and produce reactive oxygen species (ROS) in the cell lines tested. Especially, the monosubstituted complex can be reduced by ascorbic acid and forms adducts with 9-methylguanine (9MeG), which is favorable for the formation of DNA-crosslinks in the cells.

Original languageEnglish
Article numbere202200695
JournalChemistry and Biodiversity
Volume19
Issue number10
DOIs
StatePublished - Oct 2022

Bibliographical note

Publisher Copyright:
© 2022 The Authors. Chemistry & Biodiversity published by Wiley-VHCA AG, Zurich, Switzerland.

Keywords

  • cyclovoltammetry
  • lipoic acid
  • multi-action
  • Pt(IV) prodrugs
  • ROS

Fingerprint

Dive into the research topics of 'Oxoplatin-Based Pt(IV) Lipoate Complexes and Their Biological Activity'. Together they form a unique fingerprint.

Cite this